A
new research report by Transparency Market Research offers a
comprehensive evaluation of the global Etoposide
Market. The
study, titled “Etoposide
Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast 2016 - 2024”,
is available for sale on the firm’s website.
Global
Etoposide Market: Description
Etoposide
is a derivative of epipodophyllotoxins that are derived from
Mandragora officianarum (plant). Its chemical name is
4'-demethyl-epipodophylotoxin
9-[4,6-O-(R)-ethylidene-β-D-glucopyranoside] and it was introduced
in the market in 1970. Currently, it is utilized extensively in
manufacturing drugs that help treat various human malignant diseases
such as testicular cancer, lymphomas (Hodgkin, non-Hodgkin), leukemia
and lung cancer. Other diseases that are treated by consumption of
etoposide include Ewing sarcoma, Kaposi disease, rhabdomyosarcoma,
soft tissue sarcoma, pediatric brain tumors, gastric cancer, Wilms
tumor, multiple myeloma, hepatoma, adenocarcinoma and uterine cancer.
Browse
Market Research Report @
Etoposide
acts by inhibiting the activity of topoisomerase II which is
responsible for uncoiling of deoxyribonucleic acid (DNA) and thus
affects the deoxyribonucleic acid (DNA) replication and repair.
Etoposide is usually administered in combination with various
antineoplastic drugs such as cisplatin that have different modes of
action. Etoposide is administered in the patient’s body through
oral and intravenous routes. Intravenous administration of etoposide
is given under the supervision of a doctor since overdose of the same
might result in malfunctioning of human body. Etoposide solution for
injection is available in 5 mL vial, 25 mL vial and 50 mL vial, and
the dose is 20 mg/mL. Etoposide injections are usually given to
patients whose cancer condition have not improved or have worsened
post radiation treatment or other medications.
Global
Etoposide Market: Major Products
Etopophos,
Toposar and Vepesid are some of the branded versions of the
Etoposide. Among all these, Etopophos accounts for the largest
revenue share in the total etoposide market. Rising incidence of lung
cancer has been considered as one of the major factors driving the
market for etoposide. According to the American Lung Association
(ALA), an estimated 159,260 people with lung cancer are expected to
die in the American region in 2014 that will account for
approximately 27% of all cancer deaths in the same year. Also,
increasing incidence of Ewing sarcoma will propel the growth of
etoposide market.
Global
Etoposide Market: Drivers and Restraints
The
increasing number of acquired immune deficiency syndrome (AIDS)
patients across the globe will further drive the growth of etoposide
market as people with AIDS are at the high risk of developing
Kaposi’s sarcoma. It has been estimated by the World Health
Organization that in 2012, around 35.3 million people were living
with AIDS worldwide; of these around 1.6 million people died. AIDS
also increases the risk for Hodgkin and non-Hodgkin syndrome.
Increasing number of patients suffering with gastric cancer will also
augment the growth of etoposide market. Various epidemiological
sources indicate that around 1 million people suffer from gastric
cancer every year across the globe. Despite all the advantages, the
growth of etoposide market might get hampered due to the side effects
associated with the administration of etoposide. Difficulty in
breathing or swallowing, seizures, hives, constipation, hair loss and
unusual tiredness or weakness are some of the side-effects that are
associated with etoposide.
Global
Etoposide Market: Geographical Dynamics
North
America accounted for the largest revenue share of the total
etoposide market in 2012 owing to the presence of major manufacturing
companies in the region along with the improving governmental
initiatives for the development and manufacturing of etoposide.
Asia-Pacific is expected to show highest CAGR during the forecast
period. This growth is attributed to rising incidences of various
diseases such as uterine cancer, multiple myeloma, hepatoma and
lymphoma in the region. Increasing government funding for the R&D
of etoposide will further drive the growth of etoposide market in the
region. Major players operating in the market includes Pharmedic
Laboratories Pvt. Ltd, Teva Pharmaceutical Industries Ltd, Ben Venue
Laboratories, and Accord Healthcare, Inc. among other significant
players.
Get
accurate market forecast and analysis on the Etoposide market.
Request a sample to stay abreast on the key trends impacting this
market@
The
report offers a comprehensive evaluation of the market. It does so
via in-depth qualitative insights, historical data, and verifiable
projections about market size. The projections featured in the report
have been derived using proven research methodologies and
assumptions. By doing so, the research report serves as a repository
of analysis and information for every facet of the market, including
but not limited to: Regional markets, technology, types, and
applications.
The
study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The
regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
About
Us
Transparency
Market Research (TMR) is a market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. TMR's
experienced team of Analysts, Researchers, and Consultants, use
proprietary data sources and various tools and techniques to gather
and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Us
Transparency
Market Research
90
State Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
No comments:
Post a Comment